Intrommune Therapeutics is a New York-based biotechnology company.
Intrommune Therapeutics's investors include Chemical Angel Network, Robin Hood Ventures, Red Bear Angels, Timberline Investments.
Intrommune Therapeutics is headquartered in New York, United States.
Intrommune Therapeutics is a New York-based biotechnology company.
Intrommune Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intrommune Therapeutics — Funding & Investors." VCBacked, February 8, 2022, https://www.vcbacked.co/company/intrommune-therapeutics. Accessed August 15, 2026.
VCBacked. (2022). Intrommune Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/intrommune-therapeutics
{{cite web |title=Intrommune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/intrommune-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated